About Avvio Medical
Avvio Medical is a private company based in San Francisco, California. It has reported $38,032,261 raised in three offerings on Form D since February 2020.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Oct 15, 2024 | Nov 13, 2024 | $7,139,681of $15.0M target | 25 | $285K | Debt, Options, Securities on exercise, Simple Agreements for Future Equity, Convertible Promissory Notes, and Preferred Stock Warrants and the underlying capital stock issuable upon conversion and exercise thereof.Rule 506(b) | Form D ↗ |
| Jul 25, 2022 | Jul 27, 2022 | $5,709,998of $16.0M target | 5 | $1.1M | EquityRule 506(b) | Form D ↗ |
| Feb 11, 2020 | Feb 26, 2020amended Feb 16, 2021 | $25,182,582of $34.6M target | 67 | $375K | Equity, Options, Securities on exerciseRule 506(b) | Form D/A ↗1 earlier filing |
| Total, three offerings | $38,032,261 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Avvio Medical's Form D filed Nov 13, 2024.
PM
Paul Molloy
Executive officer and director
TY
Theresa Yu
Director
DW
Dongxue Wang
Director
QS
Quinten Stevens
Director
BT
Barry Templin
Director
GJ
Gregory Johnstone
Chief Financial Officer
TK
Thomas Kenny
Director
AA
Alex Andrianopoulos
Director
BH
Biao He
Director
Earlier filings also listed John Garcia (director, last listed Jul 2022), Gordon Saul (director, last listed Jul 2022), Changan Li (director, last listed Jul 2022), Ben Zadik (chief financial officer, last listed Jul 2022) and Liu Chang (director, last listed Feb 2021).